Experience real-time quotes, in-depth charts, and analyst ratings

MARKET

LMAT

LeMaitre

NASDAQ

Real-time Quotes | Nasdaq Last Sale

49.19

+0.55

+1.13%

After Hours: 49.19 0 0.00% 16:22 05/14 EDT

OPEN

48.80

PREV CLOSE

48.64

HIGH

49.75

LOW

48.44

VOLUME

101.77K

TURNOVER

52 WEEK HIGH

54.96

52 WEEK LOW

23.40

MARKET CAP

1.01B

P/E (TTM)

42.26

LeMaitre Vascular (LMAT) Insider Makes Significant Share Sale

MT Newswires · 1d ago

Lemaitre Vascular Inc (LMAT) Chairman and CEO George W Lemaitre Sold $2.4 million of Shares

GuruFocus News · 1d ago

Insider Trends: Insider Sales Continue 90-Day Trend at LeMaitre Vascular

MT Newswires · 2d ago

10-Q: LEMAITRE VASCULAR INC

(EDGAR Online via COMTEX) -- Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations This Quarterly Report on Form 10-Q...

Edgar Online - (EDG = 10Q, 10K) · 5d ago

Insider Trends: Insider Prolongs 90-Day Selling Trend at LeMaitre Vascular

MT Newswires · 5d ago

Lemaitre Vascular Inc (LMAT) Chairman and CEO George W Lemaitre Sold $4.8 million of Shares

GuruFocus News · 5d ago

Neurovascular Embolectomy Device Market Size and Share Estimation 2021 Global Industry Forthcoming Demand, Latest Trends, Development Strategy, Emerging Technologies, and Comprehensive Analysis | Industry Research Biz

May 07, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." A recent research report on the Global...

The Express Wire · 05/07 09:05

Significant Insider Sales in Shares of LeMaitre Vascular (LMAT) Extends the Selling Trend of Last Quarter

MT Newswires · 05/06 22:20

Forecast

Actual (USD)

Estimate (USD)

Income StatementMore

Net Income (USD)

YoY (%)

Balance SheetMore

Total Assets (USD)

Total Liabilities (USD)

Debt to Asset (%)

Cash FlowMore

Operating (USD)

YoY (%)

Learn about the latest financial forecast of LMAT. Analyze the recent business situations of LeMaitre through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.

Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average LMAT stock price target is 59.80 with a high estimate of 65.00 and a low estimate of 55.00.

EPS

Institutional Holdings

Institutions: 240

Institutional Holdings: 19.37M

% Owned: 94.01%

Shares Outstanding: 20.61M

TypeInstitutionsShares

Increased

449.98K

New

289.71K

Decreased

428.36K

Sold Out

86.82K

Performance
Asset Allocation
Dividend History

No Data

Industry

Advanced Medical Equipment & Technology

+1.10%

Healthcare Equipment & Supplies

+1.17%

Key Executives

President/Director

David Roberts

Chief Financial Officer/Director

Joseph Pellegrino

Senior Vice President/General Counsel

Laurie Churchill

Senior Vice President

Andrew Hodgkinson

Senior Vice President

Trent Kamke

Vice President - Operations

Stephane Maier

Vice President/Director of Sales

Giovannella Deiure

Vice President/Director of Sales

Chance Kriesel

Vice President/Director of Marketing

Kimberly Cieslak

Vice President

Roli Kumar-Choudhury

Vice President

Jonathan Ngau

Vice President

Jacob Petersen

Vice President

Xiang Zhang

Vice President - Research & Development

Ryan Connelly

Director of Sales

Helen Goulding

Other

James Russell

Independent Director

Lawrence Jasinski

Independent Director

John O'Connor

Independent Director

Bridget Ross

Independent Director

John Roush

Declaration Date Dividend Per Share Ex-Div Date: 04/27/2021
Dividend USD 0.11
05/18/2021; 02/23/2021
Dividend USD 0.11
03/08/2021; 10/20/2020
Dividend USD 0.095
11/18/2020; 07/21/2020
Dividend USD 0.095
08/26/2020; 04/28/2020
Dividend USD 0.095
05/19/2020; 01/30/2020
Dividend USD 0.095
03/02/2020; 10/21/2019
Dividend USD 0.085
11/19/2019; 07/22/2019
Dividend USD 0.085
08/20/2019; 04/29/2019
Dividend USD 0.085
05/21/2019; 02/14/2019
Dividend USD 0.085
03/21/2019; 10/04/2018
Dividend USD 0.07
11/19/2018; 07/23/2018
Dividend USD 0.07
08/21/2018; 04/23/2018
Dividend USD 0.07
05/21/2018; 02/15/2018
Dividend USD 0.07
03/21/2018; 10/24/2017
Dividend USD 0.055
11/21/2017; 07/25/2017
Dividend USD 0.055
08/21/2017; 04/24/2017
Dividend USD 0.055
05/22/2017; 02/16/2017
Dividend USD 0.055
03/20/2017; 10/24/2016
Dividend USD 0.045
11/17/2016; 07/25/2016
Dividend USD 0.045
08/18/2016; 04/25/2016
Dividend USD 0.045
05/23/2016; 02/22/2016
Dividend USD 0.045
03/17/2016; 10/22/2015
Dividend USD 0.04
11/18/2015; 07/23/2015
Dividend USD 0.04
08/18/2015; 04/23/2015
Dividend USD 0.04
05/20/2015; 02/23/2015
Dividend USD 0.04
03/18/2015; 10/23/2014
Dividend USD 0.035
11/18/2014; 07/24/2014
Dividend USD 0.035
08/19/2014; 04/24/2014
Dividend USD 0.035
05/20/2014; 02/20/2014
Dividend USD 0.035
03/18/2014; 10/23/2013
Dividend USD 0.03
11/18/2013; 07/24/2013
Dividend USD 0.03
08/19/2013; 04/24/2013
Dividend USD 0.03
05/20/2013; 02/21/2013
Dividend USD 0.03
03/18/2013; 10/30/2012
Dividend USD 0.025
11/16/2012; 07/25/2012
Dividend USD 0.025
08/15/2012; 04/25/2012
Dividend USD 0.025
05/16/2012; 02/23/2012
Dividend USD 0.025
03/16/2012; 10/25/2011
Dividend USD 0.02
11/21/2011; 07/26/2011
Dividend USD 0.02
08/17/2011; 04/26/2011
Dividend USD 0.02
05/18/2011; 02/24/2011
Dividend USD 0.02
03/18/2011

All
Financials
Insiders

About LMAT

LeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures and markets medical devices and implants used primarily in the field of vascular surgery. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment. The Company's product lines include valvulotomes, balloon catheters, carotid shunts, biologic vascular patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, prosthetic vascular grafts, biologic vascular grafts and powered phlebectomy devices. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, VascuTape Radiopaque Tape and the XenoSure biologic patch.

Webull offers kinds of LeMaitre Vascular Inc stock information, including NASDAQ:LMAT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LMAT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LMAT stock methods without spending real money on the virtual paper trading platform.